Concepedia

Publication | Open Access

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway

77

Citations

51

References

2019

Year

References

YearCitations

Page 1